Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
GoPower offers comprehensive portable solar energy solutions, designed to save you money and reduce your environmental impact. Their user-friendly solar panels eliminate the need for complex installations, allowing easy setup anywhere. Their portable solar power stations, providing up to 1000w/1280WH at 240v, are perfect for various applications such as home offices, garden rooms, boats, events, and more. With multiple output sockets and versatile charging options including solar panels and mains electricity, GoPower provides a greener and cost-effective energy alternative.
days to go:
Extended
investment:
£10,000
Rype addresses the dilemma of choosing between expensive or low-quality office furniture that contributes to carbon emissions and waste. By remanufacturing high-quality used office furniture, Rype offers cost-effective solutions with 80% lower carbon emissions and waste, while creating local jobs. Their mission is to significantly reduce office carbon emissions and costs through sustainable, circular economy practices, including exclusive furniture ranges made from waste materials. Rype's comprehensive services encompass furniture sourcing, remanufacturing, and employing marginalized individuals, contributing to a more environmentally friendly and socially responsible approach to office furnishings.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Thrive facilitates individuals' investment in clean energy projects to create a smarter, clean energy system. With over 6,000 shareholders, we've amassed a £110m portfolio in wind, solar, hydro, and battery assets, aiming for further expansion. Our diversified portfolio yields predictable incomes and reduces carbon emissions in the UK while decreasing reliance on fossil fuels.
Our revenue primarily comes from selling electricity generated by these clean energy ventures and associated government incentives. Additionally, we earn interest by funding new clean energy projects. Future plans involve investing in building renewable generation capacity and battery storage, along with providing funding for community-owned and commercial ventures to do the same.
days to go:
Expired
investment:
£5,396,950
Sonichem responds to climate and environmental demands by developing sustainable chemicals, excluding those derived from fossils or crops used for food. They utilize sawmill waste, transforming the typically discarded woodchips and sawdust into sugars, cellulose, and lignin, essential bio-based chemicals, through their patented and scalable eco-friendly process. Achieving an impressive ratio, they turn £1 of sawdust into nearly £8 worth of these sustainable chemicals. Positioned within the rapidly growing $17 billion bio-based chemicals market, their innovation addresses the rising need for sustainable alternatives in plastics, cosmetics, and various industries, positioning Sonichem at the forefront of the eco-friendly revolution.
days to go:
Expired
investment:
£1,232,585
MysteryVibe creates doctor-recommended sexual health devices. The company combines research and engineering by onboarding leading doctors to design devices that address major sexual health issues such as erectile dysfunction, dryness and pain during intercourse. MysteryVibe has changed over 50,000 lives in 65 countries, witnessed $1 million worth of direct sales in 2020, and became the first sexual health startup to be featured on a BBC documentary. The company has received 20+ international awards including, the coveted Design Week Awards where its product, 'Crescendo', beat the Apple Watch. MysteryVibe has featured in media entities like Men's Health, Women's Health, The Daily Dot, and Forbes, to name a few. The company will use 25% of the investment to expand and scale its digital marketing campaign, 25% to launch two new products, 25% to expand its team, and 25% on building its inventory.
days to go:
Expired
investment:
£498,020
With support from the founders of Bulldog Skincare, Zoopla and Love Film, VITL's aim is to improve the nation's health by offering vitamin packs that are fully personalised to the customer. VITL uses artificial intelligence to decipher which nutrients a person needs to ensure a healthy lifestyle. Effectively cutting out the cost of a private nutritionist.
days to go:
Expired
investment:
£908,950
envoPAP is a company that specialises in manufacturing printing and packaging materials from agricultural waste. Started in 2015, the company has achieved £7.3 million in revenues across 45 countries. The European packaging market is valued at over £100 billion and the European Union (EU)are looking to ban some single-use plastic products with effect from 2021, envoPAP aims to capitalise on these developments. The year 2019 saw envoPAP introducing its product 'envoBarrier’- a material resistant to oil, water, and grease which won the 'Packaging Innovation of the Year' at the Business Green Technology Awards. In 2020, envoPAP became a certified B Corporation rendering it a business that balances purpose and profit. The investment will be used to protect its Intellectual Property (IP) and expand its team.
days to go:
Expired
investment:
£381,128
